Click here for the video animation of the ProtEmbo ® System AACHEN, Germany–(BUSINESS WIRE)–September 5, 2017– Protembis GmbH, a privately held medical device company, announced today the first ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced publication of a new study in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions that ...

SENTINEL trial to evaluate the Safety and Efficacy of the Sentinel CPS in TAVR population SANTA ROSA, CA. -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during ...

Please provide your email address to receive an email when new articles are posted on . Claret Medical announced that the FDA, via the de novo classification system, cleared its cerebral protection ...

The cerebral protection device (Sentinel Cerebral Protection System, Claret Medical) captures and removes debris dislodged during TAVR before it reaches the brain and is the first available in the ...

The manufacturer of two transcatheter aortic valve technologies that have yet to get US Food and Drug Administration (FDA) clearance announced today that it plans to purchase the company that makes ...

CAESAREA, Israel and TAMPA, Fla., Feb. 27, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients ...

Minimally invasive heart-valve replacement technology has allowed thousands of previously inoperable patients to get their hearts fixed. But some of those patients go on to develop strokes within days ...

MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection ...

AACHEN, Germany--(BUSINESS WIRE)--Protembis GmbH, a privately held medical device company, announced today the first clinical applications of its ProtEmbo ® Cerebral Protection System to complement a ...